Eitan Blank - EXALENZ BIOSCIENCE Vice President - Operations

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>EXE</div>
Mr. Eitan Blank was appointed Vice President Operations at Exalenz Bioscience Ltd. effective July 23, 2014. Prior to this role, he served as Head of Global Operations at the Company for six years
Age: 43  President Since 2014  MBA    
972 8 973 7500  http://www.exalenz.com
Blank holds a Bachelors of Engineering degree in Systems Engineering and a MBA degree, both from Tel Aviv University.

Management Efficiency

The company has return on total asset (ROA) of (25.36) % which means that it has lost $25.36 on every $100 spent on asset. This is way below average.
The company has accumulated 6.59 M in total debt with debt to equity ratio (D/E) of 0.18 which may suggest the company is not taking enough advantage from borrowing. EXALENZ BIOSCIENCE has Current Ratio of 1.9 which is within standard range for the sector.

Company Summary

Exalenz Bioscience Ltd. develops and markets advanced tools for the diagnosing and managing liver and gastroenterology disorders in Israel. Exalenz Bioscience Ltd. is based in Modiin-Maccabim-Reut, Israel. EXALENZ BIOSCIENCE is traded on Tel Aviv Stock Exchange in Israel.EXALENZ BIOSCIENCE (EXEN) is traded on Tel Aviv Stock Exchange in Israel and employs 17 people.


Ilan Oren, CTOView
Susan Alpert, Vice President of RegulationView
Nachum Shamir, DirectorView
Ari Soae, Vice President-Supply ChainView
Eitan Blank, Vice President - OperationsView
Shmuel Rubinstein, DirectorView
Nisim Bilman, Vice President - Research & DevelopmentView
Saul Yemal, External DirectorView
Avi Zigelman, External DirectorView
David Stolick, CFOView
Itai Arkin, DirectorView
Sharon Kochan, External DirectorView
Gad Keren, External DirectorView
Menachem Inbar, DirectorView
Michal Hershkovitz, Vice President-Regulation & Quality AssuranceView
Raphael Werner, COOView
Einat Zisman, DirectorView
Ofer Schlesinger, Vice President - Research & DevelopmentView
Niza Lipshitz, External DirectorView
Mark Hod, Vice President of Sales, North AmericaView
Uri Geiger, Chairman of the BoardView
Roy Golan, President Vice President - FinanceView
Moshe Dori, Vice President - FinanceView

Stock Performance Indicators

Current Sentiment - EXEN


Macroaxis portfolio users are insensible in their opinion about investing in EXALENZ BIOSCIENCE. What is your opinion about investing in EXALENZ BIOSCIENCE? Are you bullish or bearish?
50% Bullish
50% Bearish


Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Twitter and Weibo. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Investing Opportunities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.